Mass · Purity · Stacking · Research evidence
Peptides FAQ
Answers on peptide molecular mass, purity, stacking claims and published research — with a clear distinction between catalog specifications, lot measurements and experimental findings.
Short answer: Molecular mass, sequence, purity and vial quantity answer different questions. Catalog specifications are not lot test results, and research on one construct or model does not establish results for another. A proposed combination needs direct evidence, not just separate studies of its ingredients.
Molecular mass & sequence
What does peptide molecular mass in daltons mean?
A dalton (Da) is a unit of molecular mass. It describes the mass of a molecule, not the amount supplied in a vial. A molecular-mass label and a vial content expressed in milligrams are different specifications; neither is a measurement of the other.
Why can peptides with similar names have different masses?
A changed amino-acid sequence, terminal modification or attached chemical group changes the construct and may change its mass. Related names do not make materials interchangeable. Compare the complete written specification, including sequence and terminal chemistry, rather than assuming a shared name establishes identity.
Does an LC-MS mass match confirm the peptide sequence?
No. LC-MS measures ion mass-to-charge ratios; a compatible mass supports an assignment but does not by itself prove the sequence or position of a modification. Compare the calculated and observed values, charge states and mass convention with the written construct and matching lot documentation. Additional structural analysis may be needed to distinguish alternatives.
Why are some masses and sequences not listed in the peptide directory?
An unlisted field means the directory has no supported specification to display. It is not an invitation to substitute a textbook sequence or infer a construct from a product name. Listed catalog values remain specifications rather than lot measurements; a linked report must be checked against the exact product and batch.
Purity & lot documentation
What does HPLC peptide purity measure?
HPLC separates components under a defined analytical method. A reported purity percentage commonly represents the main peak's share of detected peak area. The result depends on the method and detection conditions; it is not automatically a mass fraction, sequence confirmation or measurement of the peptide content in a vial.
Are purity, identity and peptide content the same thing?
No. Purity describes the measured component profile, identity asks which molecule is present, and content asks how much peptide is present. Counterions, water and other material can contribute to powder mass. A high chromatographic purity result alone does not establish identity, vial quantity or biological suitability.
What should I check on a peptide Certificate of Analysis?
First match the product, strength and batch identifiers to the material in hand. Then check the test date, analytical methods, HPLC result, calculated and observed mass, and any separately measured content. Read the method and units for each result; a report only supports the measurements it actually contains.
Is a sample report evidence for my batch?
No. A report labelled Sample report is illustrative, not a test result for a purchased vial. An available published report must match the product and lot being evaluated. Check the COA library and the product's report link for the underlying document; do not assume that every catalog entry has a verified lot report.
Stacking & combination evidence
What does peptide stacking mean in research discussions?
Stacking is an informal term for combining materials. It does not define a validated experimental method or establish that the combination has been studied. A useful evidence review identifies the exact components, the model, the measured outcomes and whether the combination itself was evaluated.
Do separate studies of two peptides prove their combination works?
No. Separate findings cannot establish a combined effect, compatibility or safety. Combining materials can change stability, interactions and the interpretation of results. Direct combination evidence requires the actual combination to be tested with appropriate controls in the stated experimental model.
Does a peptide blend establish synergy?
No. A blend label describes a proposed composition, not a demonstrated interaction. Synergy requires an explicitly defined comparison against the individual components and an appropriate reference model. Evidence for one ingredient, or a related construct, cannot be presented as a controlled result for the complete blend.
Does this FAQ provide peptide stacking protocols?
No. This page discusses how to evaluate combination claims, not how to administer or combine products for use in people or animals. PeptidesDirect products are Research Use Only materials for in-vitro laboratory research. This FAQ does not provide dosing or administration guidance.
Research evidence & limitations
How should I evaluate a peptide research claim?
Locate the original study and identify the exact studied molecule, experimental model, comparator and measured outcome. Check whether the finding comes from cells, animals or human participants and whether independent studies support it. A citation to a related molecule is context, not direct evidence for the catalog product.
Do cell or animal findings establish human benefits?
No. Findings in a particular cell or animal model may inform further research, but they do not establish human efficacy or safety. Human study results also remain specific to the studied material, population and design. None of those findings authorizes human use of a Research Use Only catalog product.
Does the number of cited references tell me how strong the evidence is?
Not by itself. A reference count tells you how many sources are linked, not whether they are independent, directly relevant or reproducible. Read the actual findings and limitations. Mechanistic papers, reviews and controlled studies answer different questions, and multiple papers can describe closely related experiments.
How does the directory connect specifications with research evidence?
Each directory row separates catalog molecular mass and specified sequence from a curated research summary. Product links lead to further context and available references; lot links lead to report information where supplied. Research summaries describe studied materials and models, not proof of the identity, purity or performance of a particular vial.
Keep reading
Directory
Peptide directory
Catalog molecular mass, sequence, research summaries and available lot links.
Compound FAQ
Adamax FAQ
Two distinct mass-labelled constructs and their analytical and research limitations.
Evidence guide
Purity, identity and peptide content
Why a chromatographic percentage cannot answer every quality question.
Report guide
Reading peptide analysis reports
Match the document to the batch and interpret only the measurements it contains.
Research Use Only. All products are sold strictly for in-vitro laboratory research. Not for human consumption, therapeutic use, veterinary use or any in-vivo application. No dosing or administration guidance is provided.
